{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T03:08:21Z","timestamp":1761016101009},"reference-count":36,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2001,12,24]],"date-time":"2001-12-24T00:00:00Z","timestamp":1009152000000},"content-version":"vor","delay-in-days":632,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J intellect Disabil Res"],"published-print":{"date-parts":[[2000,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Five individuals with intellectual disability prescribed both a barbiturate antiepileptic drug (AED) and an antipsychotic medication were identified in a public residential facility. It was hypothesized that antipsychotic medication was prescribed at doses higher than necessary as a result of inadvertent barbiturate AED behavioural side\u2010effects thought to be part of the underlying psychiatric or behavioural condition. To test this hypothesis, barbiturate AEDs were gradually reduced, and replaced with either carbamazepine or valproic acid, and antipsychotic medication was gradually reduced as well. Challenging behaviours, such as physical aggression, self\u2010injurious behaviour and property destruction, were measured with a frequency count or partial interval recording, and retrospectively analysed for time periods of \u224860 days before phenobarbital reduction, after phenobarbital discontinuation and after the lowest antipsychotic medication dose. Challenging behaviour collectively decreased by 81.5% after barbiturate discontinuation, mean antipsychotic medication dose significantly decreased from 146 mg day<jats:sup>\u20131<\/jats:sup> (SD = 98) to 106 mg day<jats:sup>\u20131<\/jats:sup> (SD = 88) chlorpromazine equivalence, and antipsychotic medication was discontinued in the cases of two individuals. Compared to the prebarbiturate AED reduction period, challenging behaviour collectively decreased by 96.3% after the lowest antipsychotic medication dose, which confirmed that reduced antipsychotic medication was not achieved at the expense of behaviour deterioration. The data supported the hypothesis that discontinuation of barbiturate AEDs results in decreased challenging behaviour and less antipsychotic medication.<\/jats:p>","DOI":"10.1046\/j.1365-2788.2000.00273.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T06:18:10Z","timestamp":1047449890000},"page":"155-163","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Results of barbiturate antiepileptic drug discontinuation on antipsychotic medication dose in individuals with intellectual disability"],"prefix":"10.1111","volume":"44","author":[{"given":"T. E.","family":"Hanzel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. D.","family":"Bauernfeind","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. E.","family":"Kalachnik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. R.","family":"Harder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2001,12,24]]},"reference":[{"key":"e_1_2_5_2_1","first-page":"500","article-title":"Psychotropic drugs in group homes: prevalence and relation to demographic\/psychiatric variables.","volume":"99","author":"Aman M. G.","year":"1995","journal-title":"American Journal on Mental Retardation"},{"key":"e_1_2_5_3_1","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1542\/peds.76.4.644","article-title":"Behavioral and cognitive effects of anticonvulsant therapy.","volume":"76","author":"American Academy of Pediatrics Committee on Drugs (AAPCD).","year":"1985","journal-title":"Pediatrics"},{"key":"e_1_2_5_4_1","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association (APA).","year":"1995"},{"key":"e_1_2_5_5_1","volume-title":"Tardive Dyskinesia. A Task Force Report of the American Psychiatric Association","author":"American Psychiatric Association (APA).","year":"1992"},{"key":"e_1_2_5_6_1","unstructured":"BaumeisterA. A. SevinJ. A. KingB. H.(1998)Neuroleptics. In:Psychotropic Medication and Developmental Disabilities: The International Consensus Handbook(eds S. Reiss & M. G. Aman) pp.13350.Ohio State University Nisonger Center Columbus OH."},{"key":"e_1_2_5_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1983.tb04896.x"},{"key":"e_1_2_5_8_1","volume-title":"Epilepsy Management in the Multiple Handicapped","author":"Bowman Gray School of Medicine of Wake Forrest University (BGSMWFU).","year":"1991"},{"key":"e_1_2_5_9_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.35.5.722"},{"key":"e_1_2_5_10_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-199018040-00004"},{"key":"e_1_2_5_11_1","first-page":"320","article-title":"Withdrawal of barbiturate anticonvulsant drugs: prospective controlled study.","volume":"93","author":"Coulter D. L.","year":"1988","journal-title":"American Journal on Mental Retardation"},{"key":"e_1_2_5_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0896-6974(88)80059-8"},{"key":"e_1_2_5_13_1","first-page":"409","volume-title":"Antiepileptic Drugs","author":"Cramer J. A.","year":"1995"},{"key":"e_1_2_5_14_1","first-page":"351","article-title":"Antiepileptic polypharmacy, psychosocial behaviour and locus of control orientation among mentally handicapped adults living in the community.","volume":"34","author":"Espie C. A.","year":"1990","journal-title":"Journal of Mental Deficiency Research"},{"key":"e_1_2_5_15_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.140.1.112"},{"key":"e_1_2_5_16_1","unstructured":"Facts and Comparisons. (1995) Facts and Comparisons St Louis. MO."},{"key":"e_1_2_5_17_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.285.6339.423"},{"key":"e_1_2_5_18_1","volume-title":"Pharmacotherapy and Mental Retardation","author":"Gadow K. D.","year":"1988"},{"key":"e_1_2_5_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1984.tb04203.x"},{"key":"e_1_2_5_20_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.141.1.20"},{"key":"e_1_2_5_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/0891-4222(92)90012-U"},{"key":"e_1_2_5_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1988.tb04237.x"},{"key":"e_1_2_5_23_1","first-page":"279","article-title":"A national study of prescribed drugs in institutions and community residential facilities for mentally retarded people.","volume":"21","author":"Hill B. K.","year":"1985","journal-title":"Psychopharmacology Bulletin"},{"key":"e_1_2_5_24_1","first-page":"374","article-title":"Differential diagnosis of antiepileptic drug behavioral side effects in individuals with mental retardation and the use of behavioral measurement techniques.","volume":"33","author":"Kalachnik J. E.","year":"1995","journal-title":"Mental Retardation"},{"key":"e_1_2_5_25_1","first-page":"389","volume-title":"Antiepileptic Drugs","author":"Kutt H.","year":"1995"},{"key":"e_1_2_5_26_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.137.7.819"},{"key":"e_1_2_5_27_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005053-199211000-00010"},{"key":"e_1_2_5_28_1","first-page":"115","article-title":"Comparative monotherapy trial in children with epilepsy.","volume":"27","author":"McGowan M.","year":"1983","journal-title":"British Journal of Clinical Practice"},{"key":"e_1_2_5_29_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1993.01820210057007"},{"key":"e_1_2_5_30_1","first-page":"41","article-title":"Mental retardation, mental illness, and seizure diagnosis.","volume":"98","author":"Pary R.","year":"1993","journal-title":"American Journal on Mental Retardation"},{"key":"e_1_2_5_31_1","first-page":"63","article-title":"Effects of barbiturate withdrawal on behavior. Results from a barbiturate discontinuation program.","volume":"11","author":"Poindexter A. R.","year":"1992","journal-title":"Habilitative Mental Healthcare Newsletter"},{"key":"e_1_2_5_32_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-198206000-00003"},{"key":"e_1_2_5_33_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199010060-00002"},{"key":"e_1_2_5_34_1","first-page":"41","article-title":"Antiepileptic drug status in adult outpatients with mental retardation.","volume":"98","author":"Singh B. K.","year":"1993","journal-title":"American Journal on Mental Retardation"},{"key":"e_1_2_5_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-8749.1975.tb03536.x"},{"key":"e_1_2_5_36_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1983.01790220026004"},{"key":"e_1_2_5_37_1","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1542\/peds.61.5.728","article-title":"Behavior disturbance, phenobarbital, and febrile seizures.","volume":"61","author":"Wolf S. M.","year":"1978","journal-title":"Pediatrics"}],"container-title":["Journal of Intellectual Disability Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2788.2000.00273.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2788.2000.00273.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,29]],"date-time":"2023-10-29T09:54:54Z","timestamp":1698573294000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2788.2000.00273.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,4]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2000,4]]}},"alternative-id":["10.1046\/j.1365-2788.2000.00273.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2788.2000.00273.x","archive":["Portico"],"relation":{},"ISSN":["0964-2633","1365-2788"],"issn-type":[{"value":"0964-2633","type":"print"},{"value":"1365-2788","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,4]]},"assertion":[{"value":"2001-12-24","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}